Company Registration No. 02312368 (England and Wales)
RED DEER HERBS LIMITED
ANNUAL REPORT AND FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2025
RED DEER HERBS LIMITED
COMPANY INFORMATION
Directors
P A Dunne
Mrs C Sadler
Company number
02312368
Registered office
2 Keytec East
Pershore
Worcestershire
WR10 2JQ
Auditor
Kendall Wadley LLP
Merevale House
27 Sansome Walk
Worcester
WR1 1NU
Business address
Varden Road
Pershore
Worcestershire
WR10 2JQ
Bankers
HSBC Bank plc
6 Broad Street
Worcester
WR1 2EJ
RED DEER HERBS LIMITED
CONTENTS
Page
Strategic report
1
Directors' report
2
Directors' responsibilities statement
3
Independent auditor's report
4 - 6
Statement of income and retained earnings
7
Balance sheet
8
Statement of cash flows
9
Notes to the financial statements
10 - 20
RED DEER HERBS LIMITED
STRATEGIC REPORT
FOR THE YEAR ENDED 31 OCTOBER 2025
- 1 -

The directors present the strategic report for the year ended 31 October 2025.

Principal Activities

Red Deer Herbs is engaged in the processing of fresh, frozen, dried herbs and pastes supplying food manufacturers, restaurants and retailers. The business sources raw materials from both domestic and international suppliers and processes them into high-quality products across a range of formats.

Risks and uncertainties

During 2025, the business operated in a challenging trading environment. Key factors included:

- Ongoing cost pressures across raw materials, energy and logistics

- Evolving customer requirements in a competitive marketplace

- Supply chain complexities associated with international sourcing

The company continues to monitor these factors and adopts a measured approach to managing commercial and operational risk.

Performance

The Directors use a range of key performance indicators to manage progress across the business.

Despite external pressures, the company maintained a stable performance during the year through disciplined management and a continued focus on operational control.

Red Deer Herbs remains committed to delivering the highest quality products and maintaining a leading position within its category, supported consistent service delivery.

The Future

The Directors remain confident in the underlying strength of the business and its ability to operate effectively within current market conditions.

The strategic focus moving forward will be on maintaining operational control, supporting customers through reliable service, and delivering sustainable performance in a changing environment.

On behalf of the board

P A Dunne
Director
6 July 2026
RED DEER HERBS LIMITED
DIRECTORS' REPORT
FOR THE YEAR ENDED 31 OCTOBER 2025
- 2 -
The directors present their report and financial statements for the year ended 31 October 2025.
Principal activities

The principal activity is the processing of fresh, frozen, and dried herbs. We source our herbs from a variety of suppliers, both domestically and internationally, and process them into high-quality products that are sold to retailers and food manufacturers. Our produce range includes fresh herbs, frozen herbs, and dried herbs in various forms such as whole, chopped and ground.

Directors

The directorss who held office during the year and up to the date of signature of the financial statements were as follows:

P A Dunne
Mrs C Sadler
Results and dividends

The results for the year are set out on page 7.

Ordinary dividends paid amounted to £470,000. The directors do not recommend payment of a further dividend.

Auditor

In accordance with the company's articles, a resolution proposing that Kendall Wadley LLP be reappointed as auditor of the company will be put at a General Meeting.

Statement of disclosure to auditor
(a) so far as the directors are aware, there is no relevant audit information of which the company's auditors are unaware, and

(b) they have taken all the steps that they ought to have taken as directors in order to make themselves aware of any relevant audit information and to establish that the company's auditors are aware of that information.
On behalf of the board
P A Dunne
Director
6 July 2026
RED DEER HERBS LIMITED
DIRECTORS' RESPONSIBILITIES STATEMENT
FOR THE YEAR ENDED 31 OCTOBER 2025
- 3 -

The directors are responsible for preparing the annual report and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law, the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period.

In preparing these financial statements, the directors are required to:

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company’s transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

RED DEER HERBS LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF RED DEER HERBS LIMITED
- 4 -
Opinion

We have audited the financial statements of Red Deer Herbs Limited (the 'company') for the year ended 31 October 2025 which comprise the statement of income and retained earnings, the balance sheet, the statement of cash flows and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

 

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

 

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information

The other information comprises the information included in the annual report other than the financial statements and our auditor's report thereon. The directors are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

 

We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of our audit:

RED DEER HERBS LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF RED DEER HERBS LIMITED (CONTINUED)
- 5 -
Matters on which we are required to report by exception

In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the strategic report or the directors' report.

 

We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:

Responsibilities of directors

As explained more fully in the directors' responsibilities statement, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

Auditor's responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

The extent to which our procedures are capable of detecting irregularities, including fraud, is detailed below.

- an understanding of the risk assessment process (including the assessment of the risk of fraud) adopted by the Board is obtained and their attitude to risk ascertained

 

- an assessment of the susceptibility to material mis-statement of the financial statements as a result of management over-ride or fraud is made

 

- it is ensured that the engagement team have, collectively, the appropriate competence, capabilities and skills to be involved in the assignment, are fully briefed and understand the risks specific to the company

The information obtained through the assessment to risk procedures is reviewed and the following work undertaken:

 

- processes to test the outcomes of our assessment include analytical review, the relevance and accuracy of significant accounting estimates, substantive testing of significant transactions, work to identify unusual or unexpected accounting entries including the testing of journal entries, information disclosed in the financial statements is traced to supporting documentation. In all instances it is acknowledged that material mis-statements that arise from fraud may involve deliberate concealment or collusion and are, therefore, by their very nature harder to detect than those arising from error.

 

- an understanding of the legal and regulatory framework as applicable to the company is obtained together with knowledge of the procedures put in place by the company in order to comply with the same

 

It should be noted that Auditing standards limit the audit procedures required to identify non-compliance with laws and regulations to enquiry of the directors and other management and the inspection of regulatory and legal correspondence, if any.

RED DEER HERBS LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF RED DEER HERBS LIMITED (CONTINUED)
- 6 -

A further description of our responsibilities is available on the Financial Reporting Council's website at: https://www.frc.org.ul/auditorsresponsibilities. This description forms part of our auditor's report.

Use of our report

This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.

Sarah Morley BA (Hons) ACA (Senior Statutory Auditor)
For and on behalf of Kendall Wadley LLP, Statutory Auditor
Chartered Accountants
Merevale House
27 Sansome Walk
Worcester
WR1 1NU
6 July 2026
RED DEER HERBS LIMITED
STATEMENT OF INCOME AND RETAINED EARNINGS
FOR THE YEAR ENDED 31 OCTOBER 2025
- 7 -
2025
2024
Notes
£
£
Turnover
3
16,205,726
14,777,033
Cost of sales
(13,743,955)
(12,534,711)
Gross profit
2,461,771
2,242,322
Administrative expenses
(1,696,879)
(1,501,783)
Other operating income
6,543
110,151
Operating profit
4
771,435
850,690
Interest receivable and similar income
7
5,256
4,771
Profit before taxation
776,691
855,461
Tax on profit
8
(181,821)
(199,008)
Profit for the financial year
594,870
656,453
Retained earnings brought forward
4,932,375
4,685,922
Dividends
9
(470,000)
(410,000)
Retained earnings carried forward
5,057,245
4,932,375

The profit and loss account has been prepared on the basis that all operations are continuing operations.

RED DEER HERBS LIMITED
BALANCE SHEET
AS AT 31 OCTOBER 2025
31 October 2025
- 8 -
2025
2024
Notes
£
£
£
£
Fixed assets
Tangible assets
10
3,994,803
4,128,661
Current assets
Stocks
11
138,483
113,299
Debtors
12
3,619,932
3,495,959
Cash at bank and in hand
852,006
1,122,530
4,610,421
4,731,788
Creditors: amounts falling due within one year
13
(3,213,190)
(3,582,301)
Net current assets
1,397,231
1,149,487
Total assets less current liabilities
5,392,034
5,278,148
Provisions for liabilities
Deferred tax liability
14
333,542
344,526
(333,542)
(344,526)
Net assets
5,058,492
4,933,622
Capital and reserves
Called up share capital
16
1,247
1,247
Distributable profit and loss reserves
5,057,245
4,932,375
Total equity
5,058,492
4,933,622

These financial statements have been prepared in accordance with the provisions relating to medium-sized companies.

The financial statements were approved by the board of directors and authorised for issue on 6 July 2026 and are signed on its behalf by:
P A Dunne
Director
Company registration number 02312368 (England and Wales)
RED DEER HERBS LIMITED
STATEMENT OF CASH FLOWS
FOR THE YEAR ENDED 31 OCTOBER 2025
- 9 -
2025
2024
Notes
£
£
£
£
Cash flows from operating activities
Cash generated from operations
21
146,472
2,163,470
Income taxes paid
(104,554)
(119,330)
Net cash inflow from operating activities
41,918
2,044,140
Investing activities
Purchase of tangible fixed assets
(103,025)
(575,606)
Proceeds on disposal of tangible fixed assets
2,000
4,505
Interest received
5,256
4,771
Net cash used in investing activities
(95,769)
(566,330)
Financing activities
Repayment of derivatives
253,327
(253,327)
Dividends paid
(470,000)
(410,000)
Net cash used in financing activities
(216,673)
(663,327)
Net (decrease)/increase in cash and cash equivalents
(270,524)
814,483
Cash and cash equivalents at beginning of year
1,122,530
308,047
Cash and cash equivalents at end of year
852,006
1,122,530
RED DEER HERBS LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2025
- 10 -
1
Accounting policies
Company information

Red Deer Herbs Limited is a private company limited by shares incorporated in England and Wales. The registered office is 2 Keytec East, Pershore, Worcestershire, WR10 2JQ.

1.1
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Going concern

Atruet the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.

1.3
Revenue

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

 

1.4
Research and development expenditure

Research expenditure is written off against profits in the year in which it is incurred. Identifiable development expenditure is capitalised to the extent that the technical, commercial and financial feasibility can be demonstrated.

1.5
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Long leasehold land and buildings
2% on cost of buildings, land over the expected life of the building
Plant and machinery
20% on net book value/10%-33% on cost
Motor vehicles
25% straight line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.6
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount.

RED DEER HERBS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 OCTOBER 2025
1
Accounting policies
(Continued)
- 11 -

Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

 

If the recoverable amount of an asset is estimated to be less than its carrying amount, the carrying amount of the asset is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

1.7
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.

1.8
Cash and cash equivalents

Cash at bank and in hand are basic financial assets and include cash in hand and deposits held at call with banks.

1.9
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Other financial assets

Other financial assets, including investments in equity instruments which are not subsidiaries, associates or joint ventures, are initially measured at fair value, which is normally the transaction price. Such assets are subsequently carried at fair value and the changes in fair value are recognised in profit or loss, except that investments in equity instruments that are not publicly traded and whose fair values cannot be measured reliably are measured at cost less impairment.

RED DEER HERBS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 OCTOBER 2025
1
Accounting policies
(Continued)
- 12 -
Impairment of financial assets

Financial assets, other than those held at fair value through profit and loss, are assessed for indicators of impairment at each reporting end date.

 

Financial assets are impaired where there is objective evidence that, as a result of one or more events that occurred after the initial recognition of the financial asset, the estimated future cash flows have been affected. If an asset is impaired, the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in profit or loss.

 

If there is a decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been, had the impairment not previously been recognised. The impairment reversal is recognised in profit or loss.

Derecognition of financial assets

Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the company transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors and bank loans, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities.

Other financial liabilities

Derivatives, including interest rate swaps and forward foreign exchange contracts, are not basic financial instruments. Derivatives are initially recognised at fair value on the date a derivative contract is entered into and are subsequently re-measured at their fair value. Changes in the fair value of derivatives are recognised in profit or loss in finance costs or finance income as appropriate, unless hedge accounting is applied and the hedge is a cash flow hedge.

 

Debt instruments that do not meet the conditions in FRS 102 paragraph 11.9 are subsequently measured at fair value through profit or loss. Debt instruments may be designated as being measured at fair value through profit or loss to eliminate or reduce an accounting mismatch or if the instruments are measured and their performance evaluated on a fair value basis in accordance with a documented risk management or investment strategy.

Derecognition of financial liabilities

Financial liabilities are derecognised when the company’s contractual obligations expire or are discharged or cancelled.

RED DEER HERBS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 OCTOBER 2025
1
Accounting policies
(Continued)
- 13 -
1.10
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.11
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax
Deferred taxation is provided in full in respect of taxation deferred by timing differences between the treatment of certain items for taxation and accounting purposes.  The deferred tax balance has not been discounted.
1.12
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

1.13
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.14
Foreign exchange
Monetary assets and liabilities denominated in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are recorded at the rate ruling at the date of the transaction. All differences are taken to profit and loss account.
2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

RED DEER HERBS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 OCTOBER 2025
- 14 -
3
Turnover and other revenue

An analysis of the company's turnover is as follows:

2025
2024
£
£
Turnover analysed by class of business
Fresh and frozen culinary herbs
16,205,726
14,777,033
2025
2024
£
£
Other significant revenue
Interest income
5,256
4,771
4
Operating profit
2025
2024
Operating profit for the year is stated after charging/(crediting):
£
£
Exchange losses/(gains)
44,206
(22,048)
Research and development costs
191
357
Fees payable to the company's auditor for the audit of the company's financial statements
8,047
9,144
Depreciation of tangible fixed assets
200,965
142,495
Loss on disposal of tangible fixed assets
33,918
-
5
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Directors
2
2
Administration
9
10
Direct labour and technical
69
66
Total
80
78

Their aggregate remuneration comprised:

2025
2024
£
£
Wages and salaries
2,696,803
2,466,952
Social security costs
304,766
226,281
Pension costs
62,325
52,246
3,063,894
2,745,479
RED DEER HERBS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 OCTOBER 2025
- 15 -
6
Directors' remuneration
2025
2024
£
£
Remuneration for qualifying services
83,700
82,000
Company pension contributions to defined contribution schemes
2,374
2,374
86,074
84,374

The number of directors for whom retirement benefits are accruing under defined contribution schemes amounted to 2 (2024 - 2).

7
Interest receivable and similar income
2025
2024
£
£
Interest income
Interest on bank deposits
5,256
4,771
2025
2024
Investment income includes the following:
£
£
Interest on financial assets not measured at fair value through profit or loss
5,256
4,771
8
Taxation
2025
2024
£
£
Current tax
UK corporation tax on profits for the current period
211,862
130,924
Adjustments in respect of prior periods
(19,057)
218
Total current tax
192,805
131,142
Deferred tax
Origination and reversal of timing differences
(10,984)
67,866
Total tax charge
181,821
199,008
RED DEER HERBS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 OCTOBER 2025
8
Taxation
(Continued)
- 16 -

The actual charge for the year can be reconciled to the expected charge for the year based on the profit or loss and the standard rate of tax as follows:

2025
2024
£
£
Profit before taxation
776,691
855,461
Expected tax charge based on the standard rate of corporation tax in the UK of 25% (2024: 25%)
194,173
213,865
Effects of:
Adjustments in respect of prior years
(19,057)
218
Group relief
(14,052)
(35,083)
Depreciation on assets not qualifying for tax allowances
20,757
20,008
Taxation charge in the financial statements
181,821
199,008
9
Dividends
2025
2024
£
£
Final paid
470,000
410,000
10
Tangible fixed assets
Long leasehold land and buildings
Plant and machinery
Motor vehicles
Total
£
£
£
£
Cost
At 1 November 2024
4,206,265
1,313,717
90,281
5,610,263
Additions
29,745
73,280
-
0
103,025
Disposals
-
0
(59,816)
(65,531)
(125,347)
At 31 October 2025
4,236,010
1,327,181
24,750
5,587,941
Depreciation and impairment
At 1 November 2024
671,457
728,020
82,125
1,481,602
Depreciation charged in the year
83,027
114,563
3,375
200,965
Eliminated in respect of disposals
-
0
(23,898)
(65,531)
(89,429)
At 31 October 2025
754,484
818,685
19,969
1,593,138
Carrying amount
At 31 October 2025
3,481,526
508,496
4,781
3,994,803
At 31 October 2024
3,534,808
585,697
8,156
4,128,661
RED DEER HERBS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 OCTOBER 2025
10
Tangible fixed assets
(Continued)
- 17 -

Leasehold land and buildings with a carrying amount of £3,481,526 (2024 - £3,534,808) have been pledged as security for a mortgage charge.

11
Stocks
2025
2024
£
£
Finished goods and goods for resale
138,483
113,299
12
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
3,353,558
3,072,836
Corporation tax recoverable
18,670
25,983
Amounts owed by group undertakings
44,199
44,199
Derivative financial instruments
-
0
253,327
Other debtors
65,841
50,076
Prepayments and accrued income
137,664
49,538
3,619,932
3,495,959
13
Creditors: amounts falling due within one year
2025
2024
£
£
Trade creditors
2,393,308
2,558,818
Corporation tax
211,862
130,924
Other taxation and social security
71,404
53,088
Other creditors
181
18
Accruals and deferred income
536,435
839,453
3,213,190
3,582,301
RED DEER HERBS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 OCTOBER 2025
- 18 -
14
Deferred taxation

Deferred tax assets and liabilities are offset where the company has a legally enforceable right to do so. The following is the analysis of the deferred tax balances (after offset) for financial reporting purposes:

Liabilities
Liabilities
2025
2024
Balances:
£
£
Accelerated capital allowances
360,978
369,609
Retirement benefit obligations
(1,488)
(1,324)
Provisions
(25,948)
(23,759)
333,542
344,526
2025
Movements in the year:
£
Liability at 1 November 2024
344,526
Credit to profit or loss
(10,984)
Liability at 31 October 2025
333,542

The deferred tax liability set out above is expected to reverse gradually after 2025 and relates to accelerated capital allowances that are expected to mature after that date.

15
Retirement benefit schemes
2025
2024
Defined contribution schemes
£
£
Charge to profit or loss in respect of defined contribution schemes
62,325
52,246

The company operates a defined contribution pension scheme for all qualifying employees. The assets of the scheme are held separately from those of the company in an independently administered fund.

16
Share capital
2025
2024
2025
2024
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary A shares of 1p each
87,333
87,333
873
873
Ordinary B shares of 1p each
37,379
37,379
374
374
124,712
124,712
1,247
1,247

The A and B shares rank pari passu, save as noted below.

Profits available for distribution are paid to the holders of the A Ordinary shares (as a class) and B Ordinary shares (as a class) as the directors see fit.

RED DEER HERBS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 OCTOBER 2025
- 19 -
17
Financial commitments, guarantees and contingent liabilities

There is a charge over all the assets of the company to secure a loan advanced to the parent company OTPD Holdings Limited by HSBC Bank plc. At 31 October 2025 the outstanding balance amounted to £834,972.

18
Operating lease commitments
As lessee

At the reporting end date the company had outstanding commitments for future minimum lease payments under a non-cancellable operating lease relating to a piece of machinery.

2025
2024
£
£
Within 1 year
29,600
29,600
Years 2-5
123,500
126,100
153,100
155,700
19
Related party transactions
Remuneration of key management personnel

The remuneration of key management personnel is as follows.

2025
2024
£
£
Aggregate compensation
289,236
295,727
Transactions with related parties

During the year the company entered into the following transactions with related parties:

Dividends of £470,000 (2024: £410,000) were paid to OTPD Holdings Limited in the year.

The following amounts were outstanding at the reporting end date:

2025
2024
Amounts due from related parties
£
£
Entities with control, joint control or significant influence over the company
44,199
44,199
20
Ultimate controlling party
The ultimate parent company is OTPD Holdings Limited, a limited liability company which is registered and domiciled in the United Kingdom. The largest and smallest group in which the results of the company are consolidated is that headed by OTPD Holdings Limited. The address of OTPD Holdings Limited's office and its principal place of business is 2 Keytec East, Pershore, Worcestershire, United Kingdom, WR10 2JQ. Copies of the parent company's financial statements are publicly available.
RED DEER HERBS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 OCTOBER 2025
- 20 -
21
Cash generated from operations
2025
2024
£
£
Profit for the year after tax
594,870
656,453
Adjustments for:
Taxation charged
181,821
199,008
Investment income
(5,256)
(4,771)
Loss on disposal of tangible fixed assets
33,918
-
Depreciation and impairment of tangible fixed assets
200,965
142,495
Movements in working capital:
(Increase)/decrease in stocks
(25,184)
5,397
Increase in debtors
(384,613)
(246,098)
(Decrease)/increase in creditors
(450,049)
1,410,986
Cash generated from operations
146,472
2,163,470
22
Analysis of changes in net funds
1 November 2024
Cash flows
31 October 2025
£
£
£
Cash at bank and in hand
1,122,530
(270,524)
852,006
2025-10-312024-11-01falsefalsefalseCCH SoftwareCCH Accounts Production 2026.100P A DunneMrs C Sadler023123682024-11-012025-10-3102312368bus:Director12024-11-012025-10-3102312368bus:Director22024-11-012025-10-3102312368bus:RegisteredOffice2024-11-012025-10-3102312368bus:Agent12024-11-012025-10-31023123682025-10-31023123682023-11-012024-10-3102312368core:RetainedEarningsAccumulatedLosses2024-10-3102312368core:RetainedEarningsAccumulatedLosses2023-10-3102312368core:ShareCapital2025-10-3102312368core:ShareCapital2024-10-3102312368core:RetainedEarningsAccumulatedLosses2025-10-3102312368core:RetainedEarningsAccumulatedLosses2024-10-31023123682024-10-3102312368core:ShareCapitalOrdinaryShareClass22025-10-3102312368core:ShareCapitalOrdinaryShareClass22024-10-3102312368core:ShareCapitalOrdinaryShareClass32025-10-3102312368core:ShareCapitalOrdinaryShareClass32024-10-3102312368core:ShareCapitalOrdinaryShares2025-10-3102312368core:ShareCapitalOrdinaryShares2024-10-3102312368core:RetainedEarningsAccumulatedLosses2023-11-012024-10-3102312368core:CurrentFinancialInstrumentscore:WithinOneYear2025-10-3102312368core:CurrentFinancialInstrumentscore:WithinOneYear2024-10-310231236812024-11-012025-10-310231236812023-11-012024-10-31023123682024-10-31023123682023-10-3102312368core:LandBuildingscore:LongLeaseholdAssets2024-11-012025-10-3102312368core:PlantMachinery2024-11-012025-10-3102312368core:MotorVehicles2024-11-012025-10-3102312368core:UKTax2024-11-012025-10-3102312368core:UKTax2023-11-012024-10-3102312368core:LandBuildingscore:LeasedAssetsHeldAsLessee2024-10-3102312368core:PlantMachinery2024-10-3102312368core:MotorVehicles2024-10-3102312368core:LandBuildingscore:LeasedAssetsHeldAsLessee2025-10-3102312368core:PlantMachinery2025-10-3102312368core:MotorVehicles2025-10-3102312368core:LandBuildingscore:LeasedAssetsHeldAsLessee2024-11-012025-10-3102312368core:LandBuildings2024-10-3102312368core:PlantMachinery2024-10-3102312368core:MotorVehicles2024-10-3102312368core:CurrentFinancialInstruments2025-10-3102312368core:CurrentFinancialInstruments2024-10-3102312368bus:OrdinaryShareClass22024-11-012025-10-3102312368bus:OrdinaryShareClass32024-11-012025-10-3102312368bus:OrdinaryShareClass22025-10-3102312368bus:OrdinaryShareClass22024-10-3102312368bus:OrdinaryShareClass32025-10-3102312368bus:OrdinaryShareClass32024-10-3102312368bus:AllOrdinaryShares2025-10-3102312368bus:AllOrdinaryShares2024-10-3102312368core:WithinOneYear2025-10-3102312368core:WithinOneYear2024-10-3102312368core:BetweenTwoFiveYears2025-10-3102312368core:BetweenTwoFiveYears2024-10-3102312368bus:PrivateLimitedCompanyLtd2024-11-012025-10-3102312368bus:FRS1022024-11-012025-10-3102312368bus:Audited2024-11-012025-10-3102312368bus:FullAccounts2024-11-012025-10-31xbrli:purexbrli:sharesiso4217:GBP